Akums strengthens presence in regulated markets with EU GMP approvals for 2 Haridwar plants
Akums Drugs & Pharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO), has achieved a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Akums
Akums reaffirms Lacosamide’s potential for epilepsy treatment
Akums Drugs & Pharmaceuticals has highlighted lacosamide, a well-established antiepileptic drug (AED), as a versatile and…
Akums’ Hormonal Plant receives EAEU GMP certification
Akums Drugs & Pharmaceuticals has received Good Manufacturing Practice (GMP) Certification by the Eurasian Economic Union…
Akums launches Dapagliflozin + Pioglitazone tablets for type 2 diabetes
New dual-action therapy targets insulin resistance and glycaemic control
Akums announces new facility for lyophilized and sterile dosage manufacturing
In addition to lyophilized injectables, the facility is equipped to manufacture vials, ampoules, form-fill-seal (FFS) products,…
Akums Drugs and Pharmaceuticals secures patent for room temperature stable hydroxyurea oral…
Akums' new formulation addresses storage challenges and improves accessibility, especially in tribal areas
Akums appoints Amrut Medhekar as CDMO CEO
He brings over 27 years of experience in the pharma industry. His expertise spans corporate strategy, business leadership, key…
Akums unveils new formulations for Gastrointestinal patients in India
Rabeprazole sodium has demonstrated efficacy in treating gastric and duodenal ulcers, as well as GERD. Levosulpiride, the…
Akums introduces DCGI approved FDC medication
Amlodipine, Telmisartan & Metoprolol (ER) film coated tablets for treatment of resistant Hypertension
Akums’ acquires new formulation facility in Baddi
It is slated to become operational in the year 2024